These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 21486533)

  • 21. Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation.
    Nguyen TH; Tan A; Santos L; Ngo D; Edwards GA; Porter CJ; Prestidge CA; Boyd BJ
    J Control Release; 2013 Apr; 167(1):85-91. PubMed ID: 23353808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
    Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
    Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability.
    Dhumal RS; Biradar SV; Yamamura S; Paradkar AR; York P
    Eur J Pharm Biopharm; 2008 Sep; 70(1):109-15. PubMed ID: 18502628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats.
    Choi JS; Ahn JB; Park JS
    Int J Pharm; 2019 Jan; 555():135-145. PubMed ID: 30458259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process.
    Jeong SC; Kim DS; Jin SG; Youn YS; Oh KT; Li DX; Yong CS; Oh Kim J; Kim KS; Choi HG
    Pharmazie; 2018 Sep; 73(9):498-502. PubMed ID: 30223931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of Vitexin Nanoparticles by Combining the Antisolvent Precipitation and High Pressure Homogenization Approaches Followed by Lyophilization for Dissolution Rate Enhancement.
    Gu C; Liu Z; Yuan X; Li W; Zu Y; Fu Y
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29165376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.
    Gupta VR; Mutalik S; Patel MM; Jani GK
    Acta Pharm; 2007 Jun; 57(2):173-84. PubMed ID: 17507314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
    Ambrogi V; Perioli L; Marmottini F; Rossi C
    Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib.
    McDonald BF; Coulter IS; Marison IW
    Pharm Dev Technol; 2015 Mar; 20(2):211-8. PubMed ID: 24283499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine.
    Gupta P; Bansal AK
    Pharm Dev Technol; 2005; 10(2):273-81. PubMed ID: 15926676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of spray-drying to enhance celecoxib solubility.
    Fouad EA; El-Badry M; Mahrous GM; Alanazi FK; Neau SH; Alsarra IA
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1463-72. PubMed ID: 21707230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
    Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.
    Jeon D; Kim KT; Baek MJ; Kim DH; Lee JY; Kim DD
    Eur J Pharm Biopharm; 2019 Aug; 141():139-148. PubMed ID: 31150807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.
    Liu D; Xu H; Tian B; Yuan K; Pan H; Ma S; Yang X; Pan W
    AAPS PharmSciTech; 2012 Mar; 13(1):295-304. PubMed ID: 22246736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.